Head-to-head comparisons of medication uses, side effects, warnings, and more.
Entyvio (vedolizumab)
Skyrizi (risankizumab)
Entyvio (vedolizumab)
Skyrizi (risankizumab)
Summary of Entyvio vs. Skyrizi
Summary for Integrin antagonist
Prescription only
Entyvio, the brand name for vedolizumab, is an injection used to treat ulcerative colitis (UC) and Crohn's disease (CD) in adults. It belongs to a drug class called integrin antagonists that helps lower inflammation in the gut. Entyvio (vedolizumab) is an infusion that's given through the vein by a healthcare professional. After the first 2 doses, it's usually given every 2 months. If it works well, people can switch to injections under the skin every 2 weeks using prefilled syringes or pens. Side effects include headache, mild infections, and joint pain.